DENVER / May 23, 2024 / Business Wire / Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company released its 2023 Sustainability Report. The annual report provides an update regarding Modivcare’s sustainability framework, which is underpinned in four key areas: responsible business practices, member support, our team, and environmental management.
“Our 2023 Sustainability Report showcases our dedication to integrating sustainability in our business strategy while upholding responsible corporate citizenship,” said L. Heath Sampson, President and Chief Executive Officer of Modivcare. “We are further enhancing transparency and accountability for our sustainability initiatives, ensuring alignment with our corporate strategy and focus on the social determinants of health. Our team remains committed to providing high-quality supportive care services and enabling greater access to care for our members. Modivcare continues to foster an environment that celebrates the diversity and differences among our team members while promoting inclusivity. I am proud of the significant progress we have achieved in enhancing our disclosures as we continue to improve our sustainability efforts.”
Highlights from Modivcare’s 2023 Sustainability report:
Modivcare’s 2023 Sustainability Report can be found on the Company’s Investor Relations website on the governance documents page, which can be accessed by clicking this link.
About Modivcare
Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.
Last Trade: | US$11.13 |
Daily Change: | 0.24 2.20 |
Daily Volume: | 412,581 |
Market Cap: | US$158.940M |
October 23, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB